Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms

Dysregulated Janus kinase–signal transducer and activator of transcription (JAK-STAT) signaling due to activation of tyrosine kinases is a common feature of myeloid malignancies. Here we report the first human disease-related mutations in the adaptor protein LNK, a negative regulator of JAK-STAT sig...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Oh, Stephen T., Simonds, Erin F., Jones, Carol, Hale, Matthew B., Goltsev, Yury, Gibbs, Kenneth D., Merker, Jason D., Zehnder, James L., Nolan, Garry P., Gotlib, Jason
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2010
Gaiak:
Myeloid Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2924231/
https://ncbi.nlm.nih.gov/pubmed/20404132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-02-270108
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak